Global Taxifolin Market Growth 2023-2029

Global Taxifolin Market Growth 2023-2029

Taxifolin (often referred to as dihydroquercetin) is a flavanonol which is a part of the phytonutrient family (a set of chemical materials that occur evidently in flora and have more than one fitness benefits).

LPI (LP Information)' newest research report, the “Taxifolin Industry Forecast” looks at past sales and reviews total world Taxifolin sales in 2022, providing a comprehensive analysis by region and market sector of projected Taxifolin sales for 2023 through 2029. With Taxifolin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Taxifolin industry.

This Insight Report provides a comprehensive analysis of the global Taxifolin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Taxifolin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Taxifolin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Taxifolin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Taxifolin.

The global Taxifolin market size is projected to grow from US$ 163.1 million in 2022 to US$ 211 million in 2029; it is expected to grow at a CAGR of 211 from 2023 to 2029.

Global key taxifolin players include Ametis, ROBIOS and JW Health Products etc. The top 3 companies hold a share about 96%. Asia-Pacific is the largest market with a share about 34%, followed by Europe and America.

In terms of product, the product whose purity is below 92% is the largest segment with a share about 72%. And in terms of applications, the largest application is healthcare with a share about 40%.

This report presents a comprehensive overview, market shares, and growth opportunities of Taxifolin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Below 92%
92%-98%
Above 98%

Segmentation by application
Food and Beverages
Healthcare
Cosmetics
Agriculture
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ametis JSC
JW Health Products
Kalenika Group
Hefei Lifeon Pharma
ROBIOS
Kingherbs Ltd
Beton Nutrition Corporation
Xi'an Sost Biotech Co.,Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Taxifolin market?

What factors are driving Taxifolin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Taxifolin market opportunities vary by end market size?

How does Taxifolin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.